Puma Biotechnology, Inc. Email Format
Biotechnology ResearchCalifornia, United States201-500 Employees
Puma Biotechnology, Inc. is a biotechnology company focused on developing therapies to improve cancer care. Based in Los Angeles, California, the organization employs a few hundred people. The company maintains involvement with the HER2-positive breast cancer community and seeks options that may benefit patients across the breast cancer treatment spectrum. In 2022, Puma entered into an exclusive license with Takeda Pharmaceutical Co. Ltd. to develop and commercialize alisertib, a selective inhibitor of aurora kinase A, for cancer indications. Positioning itself within the biotechnology research field, Puma focuses on oncology therapies and collaboration with industry partners to advance its programs.